MYH9 and adenocarcinoma: In further analyses, MYH9 expression was significantly correlated with poorer survival in patients with either adenocarcinoma (P = 0.007) (Fig. 5B) or squamous cell carcinoma (P = 0.032) (Fig. 5C).